日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Development of a targeted oral pharmacologic duodenal exclusion therapy for the treatment of metabolic diseases.

开发针对代谢性疾病的靶向口服药物十二指肠排除疗法

期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.adu1326
Carlson Taylor L, Colbert Kevin, Vieira Marcela, Guerina Florence V, Bryant Christine L N, Habegger Kirk, Pasricha Pankaj Jay, Petersen John, Polomoscanik Steven, Jozefiak Thomas H, Nimgaonkar Ashish
代谢
肠道菌群
发表日期：2025
文献求助 收藏

Development of a unique crosslinked glycosaminoglycan for soft tissue repair: Treatment of interstitial cystitis/bladder pain syndrome

开发一种独特的交联糖胺聚糖用于软组织修复：治疗间质性膀胱炎/膀胱疼痛综合征

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0317790
Heidebrecht, Richard W Jr; Jozefiak, Thomas H; Shain, Harrison C; Skrabut, Eugene M; Saunders, Debra; Smith, Nataliya; Towner, Rheal A; Hurst, Robert
发育与干细胞
发表日期：2025
文献求助 收藏

SuperGAG biopolymers for treatment of excessive bladder permeability

用于治疗膀胱过度通透性的超GAG生物聚合物

期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.709
Towner, Rheal A; Greenwood-Van Meerveld, Beverley; Mohammadi, Ehsan; Saunders, Debra; Smith, Nataliya; Sant, Grannum R; Shain, Harrison C; Jozefiak, Thomas H; Hurst, Robert E
发表日期：2021
文献求助 收藏